Norvasc (Amlodipine)

Amlodipine, the active ingredient in Norvasc, is a calcium channel blocker presented as an oral tablet for oral use. It lowers blood pressure and relieves chest pain by relaxing vascular smooth muscle, and is prescribed for adults with essential hypertension and chronic stable angina. It is indicated for long‑term management and is available in various dose strengths to allow individualized therapy.

GNH USA supplies Norvasc as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance, and reliable logistics for global healthcare partners.

Norvasc (amlodipine) is used to manage conditions within the cardiovascular disease spectrum, particularly those involving elevated blood pressure and myocardial oxygen demand.

Essential hypertension: reduces systolic and diastolic blood pressure, improving overall cardiovascular risk profile. Chronic stable angina: enhances exercise tolerance by decreasing myocardial oxygen consumption. Vasospastic (Prinzmetal) angina: prevents coronary artery spasm, reducing the frequency of chest pain episodes.

Amlodipine may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Headache: mild to moderate intensity, often transient. - Peripheral edema: swelling of ankles or lower legs due to fluid accumulation. - Flushing: sensation of warmth and redness, especially on the face. - Dizziness: light‑headed feeling, particularly after standing. - Fatigue: general tiredness without specific cause. - Palpitations: awareness of heartbeats, usually benign.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring medical attention. - Myocardial infarction: rare occurrence of heart attack. - Hepatic dysfunction: abnormal liver enzyme elevations. - Allergic reactions: rash, itching, or swelling of face and throat. - Cardiac arrhythmias: irregular heart rhythms that may be life‑threatening.

When prescribing amlodipine, clinicians should consider several precautionary measures to ensure safe use.

Blood pressure monitoring: regularly assess to avoid excessive hypotension. Hepatic impairment: dose adjustment may be required in patients with severe liver disease. Heart failure: use with caution as peripheral edema may exacerbate symptoms. Concomitant antihypertensives: evaluate risk of additive blood pressure lowering. Abrupt discontinuation: taper gradually to prevent rebound hypertension. Store at room temperature: keep in original container, protect from moisture and light.

Amlodipine can interact with other medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., clarithromycin, itraconazole): may increase amlodipine plasma levels. - Concurrent use with other potent antihypertensives: risk of excessive hypotension. - Grapefruit juice: can elevate drug concentrations by inhibiting metabolism.

Moderate Interactions (Monitor Closely): - NSAIDs: may reduce antihypertensive effect. - Beta‑blockers: combined use can enhance bradycardia. - Diuretics: may increase risk of electrolyte imbalance. - Statins metabolized by CYP3A4 (e.g., simvastatin): potential for increased statin exposure.